关键词：骨质疏松症；药物；市场
摘 要：Osteoporosis is a disease that reduces the mass and density of a bone, resulting in an increased risk of fracture. In this disease, the risk of fracture increases due to the permeability and fragility of the bones. Often there are no symptoms observed until the first fracture occurs. Some of the risk factors responsible for osteoporosis include aging, low body weight, low sex hormones or menopause, and smoking. Osteoporosis affects men and women of all races. It is estimated that, globally, 1 in 5 men and 1 in 3 women are at risk of an osteoporotic fracture.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Osteoporosis Drugs Market in the US

06.3.1 Market Size and Forecast

06.4 Osteoporosis Drugs Market in Europe

06.4.1 Market Size and Forecast

06.5 Five Forces Analysis

07. Market Segmentation by Drug Class

08. Geographical Segmentation

08.1 Osteoporosis Drugs Market in the Americas

08.2 Osteoporosis Drugs Market in the EMEA Region

08.3 Osteoporosis Drugs Market in the APAC Region

09. Buying Criteria

10. Rate of Incidence and Prevalence

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Vendor Ranking 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Amgen Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Eli Lilly & Co.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Merck & Co. Inc.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Novartis AG

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Series